Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to ATX-304.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes NCT01167881 | ATX-304 | Phase 3 | Completed | Boehringer Ingelheim | 1,549 | Aug 2013 | Sep 2, 2016 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes NCT00508287 | ATX-304 | Phase 1 | Completed | Bristol-Myers Squibb | 36 | Nov 2007 | Mar 16, 2009 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.